A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.
about
Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and CMolecular mechanism and treatment of viral hepatitis-related liver fibrosis.Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesGenes and hepatitis C: susceptibility, fibrosis progression and response to treatment.Age and ethnicity in cirrhosis.A frequent variant in the human bile salt export pump gene ABCB11 is associated with hepatitis C virus infection, but not liver stiffness in a German population.Predicting cirrhosis and clinical outcomes in patients with advanced chronic hepatitis C with a panel of genetic markers (CRS7).Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.Role of genetic polymorphisms in hepatitis C virus chronic infection.YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis CCirrhosis and Advanced Fibrosis in Hispanics in Texas: The Dominant Contribution of Central Obesity.Fueling fibrosis in chronic hepatitis C.Host genetic variants in the pathogenesis of hepatitis C.Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosisA polymorphism that delays fibrosis in hepatitis C promotes alternative splicing of AZIN1, reducing fibrogenesisFrom cirrhosis to hepatocellular carcinoma: new molecular insights on inflammation and cellular senescence.Biomarkers of liver fibrosis.Treatment discontinuation with peg-interferon: what to consider.Genomics and proteomics in liver fibrosis and cirrhosis.Impact of common risk factors of fibrosis progression in chronic hepatitis C.Individualized medicine 2010.Molecular Epidemiology of Hepatocellular Carcinoma.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.A polymorphism linked to RRAS, SCAF1, IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers.Telomere shortening as genetic risk factor of liver cirrhosis.A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection.SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis.Telomerase mutation: a genetic risk factor for cirrhosis.Genetic variation in the interleukin -28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection
P2860
Q26781789-5167148E-41C3-47ED-B871-E0549D724EE8Q27692609-34A3DD0E-504D-4144-8976-5A1C70A5ACEBQ28272678-4F2A2CDE-CD8D-4F31-80FF-2F270E21E2FEQ33350754-5157F496-7BC8-4FCE-9FE4-8BC73D94B5B5Q34231825-6E527A4F-AC5B-4227-B282-70864CF76037Q34297774-776F121C-647B-4CED-A581-D874EAE1538DQ35547001-8A8B996C-FF92-425D-A805-D530C7A0DAF5Q35619104-4D32F0D6-0C9F-43D1-B044-04E835B9680CQ35779058-81FD28D0-F951-4341-90B2-E63DBAD5FC33Q35823055-BC5FF34B-504D-4C8C-A362-0FCF9295B601Q35948098-857E30BE-9159-4F8C-8CAE-A2BB7A8E2096Q36221650-A52C4ED6-0A88-4C54-930D-211DEA330506Q36482742-E13C4A4C-DA41-4C34-9C9B-5FAD10E6F2ECQ36788468-DD3FE1F3-850B-4B13-BB57-D4D2CE39D209Q37139990-64FEE438-27E5-442F-8E52-B80069AAF3DEQ37435652-0CE4435B-BE30-4168-A7FA-7E4FFCAE607EQ37825547-77B1E76B-824D-440D-8007-7B80D075D53BQ38599378-FF66C8D4-275F-4AFB-95DB-A087B74E8150Q40462698-3F272EF3-42F3-40E4-801A-8B5DC7CBC3B7Q41741892-D9BCB160-3523-4238-96BB-FC8166A30A4DQ41850141-4057DA6A-200F-40D5-B8C0-16F236B2CDF4Q41881227-4911F47C-BA33-4DC4-8A59-AB765EE083BFQ41921861-58B4061A-837F-4B77-8136-903AB8F502E0Q42262070-6B945E6A-1EF7-465E-B431-26D06040906DQ43103562-93FED3DD-C3DE-4A9D-BF8D-1C1F0B5634E7Q45361290-D1BA5FD6-1469-4E1E-ADC7-8FD81BE2A7ACQ47129673-15A81797-E6F0-4885-BC5C-17F00EC8C950Q53801178-84CA101C-6BF6-4ADD-857D-95088A0E58BCQ57160250-B04BDD38-804E-4928-8300-4F361F43A5A7
P2860
A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
A seven-gene signature (cirrho ...... ally mild chronic hepatitis C.
@en
A seven-gene signature
@nl
type
label
A seven-gene signature (cirrho ...... ally mild chronic hepatitis C.
@en
A seven-gene signature
@nl
prefLabel
A seven-gene signature (cirrho ...... ally mild chronic hepatitis C.
@en
A seven-gene signature
@nl
P2093
P2860
P356
P1433
P1476
A seven-gene signature (cirrho ...... ally mild chronic hepatitis C.
@en
P2093
Alfredo Alberti
Bradford Young
Francesca Dal Pero
Giada Sebastiani
Giovanna Fattovich
Laura Peraro
Maria Guido
Moira Marcolongo
P2860
P304
P356
10.1002/HEP.23111
P407
P50
P577
2009-10-01T00:00:00Z